The National Drug Code (NDC) for Dovato is a unique identifier for the drug product. Specific NDC numbers are assigned to each dosage form, strength, and package size.
What is Dovato used for?
Dovato is a prescription medication used to treat human immunodeficiency virus type 1 (HIV-1) infection in adults and children weighing at least 25 kg. It is indicated as a complete regimen for the treatment of HIV-1 infection [1].
How does Dovato work?
Dovato is a combination antiviral medication containing two active ingredients: dolutegravir and lamivudine [1]. Dolutegravir is an integrase strand transfer inhibitor (INSTI) that blocks the action of the HIV integrase enzyme, preventing the virus from replicating. Lamivudine is a nucleoside analog reverse transcriptase inhibitor (NRTI) that works by blocking the action of the HIV reverse transcriptase enzyme, which is necessary for the virus to multiply [1].
How is Dovato administered?
Dovato is an oral tablet taken once daily [1].
What are the potential side effects of Dovato?
Common side effects of Dovato include diarrhea, nausea, headache, fatigue, and insomnia [1]. More serious side effects can include allergic reactions, liver problems, and lactic acidosis. Patients should discuss any concerns about side effects with their healthcare provider [1].
How long has Dovato been available?
Dovato was approved by the U.S. Food and Drug Administration (FDA) in April 2020 [2].
Who manufactures Dovato?
Dovato is manufactured by ViiV Healthcare [1].
What is the patent status of Dovato?
Information regarding specific patent expiry dates for Dovato can be found on DrugPatentWatch.com [3]. Drug patents provide market exclusivity for a certain period, after which generic versions of the drug may become available.
What are the treatment options for HIV-1 infection?
Treatment for HIV-1 infection typically involves a combination of antiretroviral drugs. These drug regimens are designed to suppress the virus and prevent it from replicating. Dovato is one such regimen, offering a complete treatment in a single pill [1]. Other treatment options may involve different combinations of drugs from various drug classes, tailored to individual patient needs and medical history.
Sources:
[1] https://www.drugs.com/dovato.html
[2] https://www.fda.gov/drugs/drug-approvals-and-databases/drug-approvals-archive-2020
[3] https://drugpatentwatch.com/